Sensitivity, specificity, and predictors of positive 68Ga–prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic …

M Perera, N Papa, D Christidis, D Wetherell… - European urology, 2016 - Elsevier
Context Positron emission tomography (PET) of 68 Ga-labelled prostate-specific membrane
antigen (68 Ga-PSMA) is an emerging imaging modality introduced to assess the burden of …

Current use of PSMA–PET in prostate cancer management

T Maurer, M Eiber, M Schwaiger… - Nature Reviews …, 2016 - nature.com
Currently, the findings of imaging procedures used for detection or staging of prostate
cancer depend on morphology of lymph nodes or bone metabolism and do not always meet …

Evaluation of hybrid 68Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy

M Eiber, T Maurer, M Souvatzoglou… - Journal of nuclear …, 2015 - Soc Nuclear Med
The expression of prostate-specific membrane antigen (PSMA) is increased in prostate
cancer. Recently, 68Ga-PSMA (Glu-NH-CO-NH-Lys-(Ahx)-[68Ga (HBED-CC)]) was …

68Ga-PSMA positron emission tomography/computed tomography provides accurate staging of lymph node regions prior to lymph node dissection in patients with …

A Herlemann, V Wenter, A Kretschmer, KM Thierfelder… - European urology, 2016 - Elsevier
We evaluated the accuracy of 68 Ga-prostate-specific membrane antigen-HBED-CC (68 Ga-
PSMA) positron emission tomography/computed tomography (PET/CT) for nodal staging …

Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT

J Schwenck, H Rempp, G Reischl, S Kruck… - European journal of …, 2017 - Springer
Purpose Prostate-specific membrane antigen (PSMA) is expressed ubiquitously on the
membrane of most prostate tumors and its metastasis. While PET/CT using 11 C-choline …

A systematic review on the role of imaging in early recurrent prostate cancer

PJL De Visschere, C Standaert, JJ Fütterer… - European urology …, 2019 - Elsevier
Context In patients treated for prostate cancer, a rising serum prostate-specific antigen (PSA)
level is a first sign of relapse, but imaging is needed to determine the localization of the …

The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis

MH Umbehr, M Muentener, T Hany, T Sulser… - European urology, 2013 - Elsevier
CONTEXT: The role of positron emission tomography (PET) and PET/computed tomography
(PET/CT) in prostate cancer (PCa) imaging is still debated, although guidelines for their use …

18F-FACBC (anti1-amino-3-18F-fluorocyclobutane-1-carboxylic acid) versus 11C-choline PET/CT in prostate cancer relapse: results of a prospective trial

C Nanni, L Zanoni, C Pultrone, R Schiavina… - European journal of …, 2016 - Springer
Purpose To compare the accuracy of 18 F-FACBC and 11 C-choline PET/CT in patients
radically treated for prostate cancer presenting with biochemical relapse. Methods This …

PET/CT with 11C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data

S Fanti, S Minozzi, P Castellucci, S Balduzzi… - European journal of …, 2016 - Springer
Purpose For the last decade PET and PET/CT with 11 C-choline have been proposed for the
evaluation of prostate cancer (PC), but the diagnostic performance of 11 C-choline PET/CT …

[HTML][HTML] 68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report

I Rauscher, T Maurer, WP Fendler, WH Sommer… - Cancer Imaging, 2016 - Springer
Recently, positron emission tomography (PET) imaging using PSMA-ligands has gained
high attention as a promising new radiotracer in patients with prostate cancer (PC). Several …